Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Jun 21, 2026, 14:23Orton Lungu: Navigating High-Risk Pregnancy in Women Living With Sickle Cell Disease
-
Jun 21, 2026, 14:11Alexandre Kauskot: A Guide to Paris’s Best Riverside Spots for ISTH 2026 Attendees
-
Jun 21, 2026, 14:10Avidesh Panday: Data-Driven Stroke Care Transformation at EWMSC
-
Jun 21, 2026, 13:41Emmanuel J. Favaloro: Honored to Receive the ISLH Wallace H. Coulter Distinguished Lecture Award
-
Jun 21, 2026, 11:50Khalil Ahmad: The Incredible Journey of a Red Blood Cell – A Lifelong Mission of Oxygen Delivery
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:50Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition
-
Jun 21, 2026, 07:39Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies